Why This Renowned Dermatologist Chooses This Neurotoxin
Real-World Insights: Systemic Therapies in Moderate to Severe Atopic Dermatitis Patients
These insights highlight the crucial role of systemic therapies in the comprehensive management of moderate to severe atopic dermatitis.
Larry Eichenfield, MD, Addresses Pediatric AD, Upcoming Therapies, and Misinformation From Social Media
As cold weather is approaching for much of the country, it is crucial for dermatologists, pediatricians, and families to work together for proper pediatric atopic dermatitis care.
SARS-CoV-2 Associated With Increased Incidence of Psoriasis
In a cohort of patients in the UK, investigators found that SARS-CoV-2 was associated with increased incidence of several immune-mediated inflammatory diseases, with psoriasis among them.
Stefan Weiss, MD, Discusses OM1’s New HS Dataset and Expanded Dermatology Network
The addition of an HS dataset adds approximately 26,000 new patient records.
Discovering Last Month's Psoriasis Spotlight
The September 2023 issue of Dermatology Times featured a spotlight on psoriasis research, advances, and treatment options in patients with skin of color. Learn more about the topics covered in each spotlight article.
Jeremy Brauer, MD, Publishes Men’s Aesthetics Textbook
Brauer’s textbook can be purchased through Amazon and Barnes & Noble.
Get Ready to Test Your Atopic Dermatitis Knowledge
Check in throughout the month to learn more about the latest treatment pearls and research findings in DermIQ’s spotlight on atopic dermatitis.
Risankizumab Efficacious in Patients With Concomitant Psoriasis and HIV, Study Reports
Investigators reported successful treatment of psoriasis with risankizumab, despite presence of concomitant HIV infection in 4 male patients.
FDA Issues Complete Response Letter for Lebrikizumab
No concerns were cited about the clinical data package, safety, or label of lebrikizumab.
Eczema Resources for Your Patients: Week 1
Prepare your patients with helpful resources each week throughout National Eczema Awareness Month.
SLIDESHOW: Drug and Treatment Spotlights at Maui Derm NP+PA Fall
New and emerging therapies to treat a variety of skin conditions were presented by George Martin, MD, and Ted Rosen, MD.
Editorial Advisory Board Insights for Eczema Awareness Month: Raj Chovatiya, MD, PhD
Raj Chovatiya, MD, PhD, shares his atopic dermatitis insights.
Spotlighting Advances in Atopic Dermatitis Research and Prevention Strategies
October is Eczema Awareness Month and Dermatology Times is recognizing research to best serve patients with the most common type of eczema, atopic dermatitis.
Derm In The News: September 24-30
Keep up with the latest headlines in dermatology from the past week, including new research into artificial intelligence skin tone bias, dermatologic care of the unhoused patient population, and more.
A Hairy Q&A With Jerry Shapiro, MD
The hair guru explains how he opened up the first dermatology practice dedicated to hair, pearls from his session, innovative therapies, and research he has recently submitted.
The Importance of Timing With Live Vaccinations in Pediatric Atopic Dermatitis
Colleen Cotton, MD, does a deep dive on pediatric atopic dermatitis and explains the importance of timing and conversations with patients about different treatments.
Evaluating Efficacy of Trifarotene in Latin American Patients With Acne
Trifarotene emerges as an effective and well-tolerated solution for acne across diverse populations.
Discovering Dermatology Times: September 2023 BCC Management Supplement
Learn more about the in-depth topics covered in the September 2023 Frontline Forum BCC management supplement of Dermatology Times.
Understanding Eyebrow and Eyelash Hair Loss in Severe Alopecia Areata
The distribution of eyebrow and eyelash hair loss in relation to the severity of scalp hair loss remains underexplored, and this study established baseline characteristics.
Incyte to Present Numerous Studies at EADV 2023
Late-breaking data, oral presentations, and ePosters from Incyte’s dermatology portfolio will be presented in Berlin, Germany, October 11-14.
Data-Driven Advice for Health Care Workers Experiencing Contact Dermatitis
Matthew Zirwas, MD, addressed solutions to the toll consistent handwashing, sanitizing, and wearing gloves can take on hands.
Prolonged Remission in Rosacea: A Breakthrough With Subantibiotic Dose of Oral Doxycycline
Researchers found that continued use of once-daily subantibiotic dose oral doxycycline 40 mg modified-release capsules significantly reduced the relapse rate and inflammatory lesion counts in patients with moderate-to-severe rosacea.
Rocco Serrao, MD Looks Ahead to Bimekizumab’s Approval
We had the chance to catch up with Serrao before he took the stage and he explained why dermatology clinicians should keep their eyes on bimekizumab’s data and shared opportunities for further research.
DEF and SDPA Partner to Emphasize Cardiovascular Health for World Heart Day
NPs and PAs in dermatology are encouraged to monitor their own cardiovascular health and support their peers.
Discovering Dermatology Times: September 2023
Learn more about the in-depth topics covered in the September 2023 print issue of Dermatology Times.
85% of Survey Respondents Do Not Know What Actinic Keratosis Is
The survey conducted by Almirall included participants in the US and Europe.
Colleen Cotton, MD, Explains Conditions Often Mistaken For Pediatric Acne
In a Q&A, she shares pearls from her personal experiences treating pediatric acne and other underlying conditions that may require a multidisciplinary plan.
Understanding the Impact of Prurigo Nodularis Itch, Sleep Loss, and Quality of Life
The intense itching associated with prurigo nodularis significantly affects patients’ quality of life, leading to higher rates of anxiety, depression, and sleep disturbances.
2023 Dermatology Research to Ponder
Leaders in dermatology shared a review of thought-provoking literature published this year to consider in practice, diagnostic solutions, and treatment strategies.
2 Clarke Drive Cranbury, NJ 08512